Literature DB >> 15299757

Structure determination of coxsackievirus B3 to 3.5 A resolution.

J K Muckelbauer1, M Kremer, I Minor, L Tong, A Zlotnick, J E Johnson, M G Rossmann.   

Abstract

The crystal structure of coxsackievirus B3 (CVB3) has been determined to 3.5 A resolution. The icosahedral CVB3 particles crystallize in the monoclinic space group, P2(1), (a = 574.6, b = 302.1, c = 521.6 A, beta = 107.7 degrees ) with two virions in the asymmetric unit giving 120-fold non-crystallographic redundancy. The crystals diffracted to 2.7 A resolution and the X-ray data set was 55% complete to 3.0,4, resolution. Systematically weak reflections and the self-rotation function established pseudo R32 symmetry with each particle sitting on a 32 special position. This constrained the orientation and position of each particle in the monoclinic cell to near face-centered positions and allowed for a total of six possible monoclinic space-group settings. Correct interpretation of the high-resolution (3.0-3.2 A) self-rotation function was instrumental in determining the deviations from R32 orientations of the virus particles in the unit cell. Accurate particle orientations permitted the correct assignment of the crystal space-group setting amongst the six ambiguous possibilities and for the correct determination of particle positions. Real-space electron-density averaging and phase refinement, using human rhinovius 14 (HRV14) as an initial phasing model, have been carried out to 3.5 A resolution. The initial structural model has been built and refined to 3.5 A resolution using X-PLOR.

Entities:  

Year:  1995        PMID: 15299757     DOI: 10.1107/S0907444995002253

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  30 in total

1.  Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16.

Authors:  A T Hadfield; G D Diana; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.

Authors:  Steven D Carson; Nora M Chapman; Susan Hafenstein; Steven Tracy
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 3.  Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.

Authors:  Anna Egorova; Sean Ekins; Michaela Schmidtke; Vadim Makarov
Journal:  Eur J Med Chem       Date:  2019-06-11       Impact factor: 6.514

Review 4.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes.

Authors:  D Hober; F Sane; H Jaïdane; K Riedweg; A Goffard; R Desailloud
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

5.  Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1.

Authors:  C Xiao; C M Bator; V D Bowman; E Rieder; Y He; B Hébert; J Bella; T S Baker; E Wimmer; R J Kuhn; M G Rossmann
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 6.  Virus Isoelectric Point Estimation: Theories and Methods.

Authors:  Joe Heffron; Brooke K Mayer
Journal:  Appl Environ Microbiol       Date:  2021-01-15       Impact factor: 4.792

7.  Improved Virus Isoelectric Point Estimation by Exclusion of Known and Predicted Genome-Binding Regions.

Authors:  Joe Heffron; Brooke K Mayer
Journal:  Appl Environ Microbiol       Date:  2020-11-10       Impact factor: 4.792

8.  MOPS and coxsackievirus B3 stability.

Authors:  Steven D Carson; Susan Hafenstein; Hyunwook Lee
Journal:  Virology       Date:  2016-12-08       Impact factor: 3.616

9.  A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.

Authors:  Damian M Carragher; Denise A Kaminski; Amy Moquin; Louise Hartson; Troy D Randall
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

10.  Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds.

Authors:  Ying Zhang; Alan A Simpson; Rebecca M Ledford; Carol M Bator; Sugoto Chakravarty; Gregory A Skochko; Tina M Demenczuk; Adiba Watanyar; Daniel C Pevear; Michael G Rossmann
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.